Skip to main content
Premium Trial:

Request an Annual Quote

Life Technologies to Distribute Luminex's Magpix

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex announced after the close of the market Wednesday that Life Technologies will sell and distribute the firm's Magpix instrument worldwide.

Magpix, which was launched last year, is a compact multiplex analyzer that rapidly detects 50 different analytes simultaneously on a single sample, including proteins and nucleic acids. The system is based on Luminex's xMAP technology and provides nearly 5,000 data points in under an hour.

"Magpix represents a unique platform through which Life Technologies can make its cutting-edge antibody content accessible for a broad range of protein quantitation needs in basic and clinical research," Peter Dansky, president of molecular and cell biology at Life Technologies, said in a statement.

Financial and other terms of the agreement were not disclosed.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.